DMMR COLORECTAL CANCER
Clinical trials for DMMR COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new DMMR COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for DMMR COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer combo trial pulled before it began
Disease control TerminatedThis study was designed to test two immunotherapy drugs, monalizumab and MEDI5752, in people with MSI/dMMR metastatic cancer. These cancers have a genetic feature that makes them more responsive to immunotherapy. However, the trial was withdrawn before enrolling any participants,…
Matched conditions: DMMR COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
Tissue collection study aims to build smarter cancer test
Knowledge-focused OngoingThis study collects tumor tissue from about 416 people with various advanced cancers to develop and train a new diagnostic platform called Elephas. The goal is to see how accurately the platform can predict whether a patient will respond to immunotherapy, compared to standard met…
Matched conditions: DMMR COLORECTAL CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated May 17, 2026 00:40 UTC